NCT00714116 - Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG

SBI-087

Single IV or SC dose of SBI-087

Trial Locations (6)

Altoona Center for Clinical Research, Duncansville

Duke University Medical Center, Durham

Arthritis & Rheumatology Care Center, South Miami

Miami Research Associates, South Miami

MRA Clinical Research, South Miami

Metroplex Clinical Research Center, Dallas